» Articles » PMID: 9383983

Receptor Site and Stereospecifity of Dihydrolipoamide Dehydrogenase for R- and S-lipoamide: a Molecular Modeling Study

Overview
Journal J Biotechnol
Date 1998 Jan 10
PMID 9383983
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The binding of the substrate R-dihydrolipoamide to the active site of dihydrolipoamide dehydrogenase has been investigated by molecular modeling and energy-minimization studies on the basis of the resolved 3-dimensional structure of the enzyme from Azotobacter vinelandii (PDB entry 3LAD) which was determined without its bound substrate. The binding model is used as a template for a FIELD-FIT docking procedure for the inactive S-enantiomer of dihydrolipoamide which is an inhibitor of the enzyme. Results show that only the active R-enantiomer is able to form direct contacts with the reactive thiol groups and imidazol base at the active site, whereas with the S-enantiomer the SH-group at C6 points away from the His450* base. Evaluation of the binding energy to the receptor site yields nearly the same value for both enantiomers. This is in accordance with experimental results which show that the stereospecifity of dihydrolipoamide dehydrogenase occurs more at the level of catalysis than of binding. The substrate/receptor model is extended to the binding of lipoyllysine, the substrate of dihydrolipoamide dehydrogenase, when the enzyme is integrated into the pyruvate dehydrogenase complex. The penetration-site of the lipoyllysine arm into the structure of dihydrolipoamide dehydrogenase could be identified. The consequences for the interaction of dihydrolipoamide dehydrogenase with the lipoyl domain of the alpha-oxoacid dehydrogenase complexes are discussed.

Citing Articles

The Use of Alfa-Lipoic Acid-R (ALA-R) in Patients with Mild-Moderate Carpal Tunnel Syndrome: A Randomised Controlled Open Label Prospective Study.

Passiatore M, Perna A, De-Vitis R, Taccardo G Malays Orthop J. 2020; 14(1):1-6.

PMID: 32296475 PMC: 7156176. DOI: 10.5704/MOJ.2003.001.


Underlying molecular alterations in human dihydrolipoamide dehydrogenase deficiency revealed by structural analyses of disease-causing enzyme variants.

Szabo E, Wilk P, Nagy B, Zambo Z, Bui D, Weichsel A Hum Mol Genet. 2019; 28(20):3339-3354.

PMID: 31334547 PMC: 7275779. DOI: 10.1093/hmg/ddz177.


Unified theory of Alzheimer's disease (UTAD): implications for prevention and curative therapy.

Nehls M J Mol Psychiatry. 2016; 4:3.

PMID: 27429752 PMC: 4947325. DOI: 10.1186/s40303-016-0018-8.


Global Kinetic Analysis of Mammalian E3 Reveals pH-dependent NAD+/NADH Regulation, Physiological Kinetic Reversibility, and Catalytic Optimum.

Moxley M, Beard D, Bazil J J Biol Chem. 2015; 291(6):2712-30.

PMID: 26644471 PMC: 4742739. DOI: 10.1074/jbc.M115.676619.


Reduction of conjunctival fibrosis after trabeculectomy using topical α-lipoic acid in rabbit eyes.

Ekinci M, Cagatay H, Ceylan E, Keles S, Koban Y, Gokce G J Glaucoma. 2014; 23(6):372-9.

PMID: 25055213 PMC: 4162338. DOI: 10.1097/IJG.0000000000000052.